ONCOCYTE CORP (OCX) Stock Cash Flow
NASDAQ:OCX - Nasdaq - US68235C2061 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -58.20M | -60.66M | -27.78M | -72.90M | -64.10M | |||
| Depreciation Amortization | 1.72M | 1.56M | 1.68M | 5.22M | 4.20M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | -9.26M | |||
| Change In Working Capital | -3.38M | -1.32M | -3.97M | -1.94M | -2.20M | |||
| Interest Paid | 66.00K | 42.00K | 0.00 | 20.00K | 110.00K | |||
| Taxes Paid | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Other non cash items | 37.13M | 39.71M | 6.75M | 24.06M | 35.42M | |||
| OPERATING CASH FLOW | -22.74M | -20.71M | -23.32M | -45.57M | -35.94M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -799.00K | -516.00K | -281.00K | -4.34M | -2.25M | |||
| Other Investing Activity | N/A | 4.00K | -651.00K | 0.00 | -11.71M | |||
| INVESTING CASH FLOW | -795.00K | -512.00K | -932.00K | -4.34M | -13.96M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -299.00K | -201.00K | -117.00K | -1.43M | -1.53M | |||
| Stock Issued/Repurchased | N/A | 22.43M | 12.73M | 37.72M | 82.96M | |||
| Other Financing Activity | N/A | -1.79M | -427.00K | -480.00K | -3.07M | |||
| FINANCING CASH FLOW | 48.99M | 20.43M | 12.19M | 35.81M | 78.36M | |||
| CHANGE IN CASH | 25.45M | -796.00K | -12.07M | -14.10M | 28.46M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.74M | -20.71M | -23.32M | -45.57M | -35.94M | |||
| Capital Expenditure | -799.00K | -516.00K | -281.00K | -4.34M | -2.25M | |||
| FREE CASH FLOW | -23.54M | -21.23M | -23.61M | -49.91M | -38.19M | |||
All data in USD